Dexamethasone Could Save Critically Ill Coronavirus Patients

Dexamethasone could save critically ill Coronavirus patients!

The latest news on the Coronavirus disease front is that the corticosteroid Dexamethasone, could prove to be a lifesaving drug, for those patients who are critically ill due to Coronavirus. The initial clinical trial results of this, have come from the United Kingdom.

Dr Tedros Adhanom Ghebreyesus, WHO Director-General, has welcomed these trials, stating:

“This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support. This is great news and I congratulate the Government of the UK, the University of Oxford, and the many hospitals and patients in the UK who have contributed to this lifesaving scientific breakthrough.”

He added:

“Dexamethasone, a common steroid, has been shown to have beneficial effect on patients severely ill with Covid-19. According to early findings shared with WHO, for patients on oxygen alone, dexamethasone treatment was shown to reduce mortality by about one-fifth.”

For those Coronavirus patients who are on ventilators, Dexamethasone treatment has shown to reduce mortality by around 1/3rd. And for those New Coronavirus patients who required only oxygen, the mortality was cut by about 1/5th. These were the preliminary findings that have been shared with WHO.

Dr Tedros Adhanom Ghebreyesus further stated:

“The world has now recorded more than 8 million cases of Covid-19. In the first two months, 85,000 cases were reported. In the past two months, six million cases have been reported. However, there are green shoots of hope, which show that together through global solidarity, humanity can overcome this pandemic.”

But the benefit of Dexamethasone treatment, was only seen in Novel Coronavirus patents who are seriously ill. It has not been seen in patients who have a milder form of the Coronavirus disease.

Mike Ryan, Head of the World Health Organizations’s emergencies programme said:

“It’s exceptionally important in these cases that the drug is reserved for severely ill and critical patients who can benefit from this clearly.”

Matt Hancock, UK health minister said:

“It’s the first time that anyone in the world has clinically proven that a drug can improve the survival chances of the most seriously ill Coronavirus patients.”

Leave a Reply

Your email address will not be published. Required fields are marked *